Classical Complement Pathway Inhibition in a “Human‐On‐A‐Chip” Model of Autoimmune Demyelinating Neuropathies
2022 · Advanced Therapeutics · 71 citations
https://doi.org/10.1002/adtp.202200030
S
Shruti M. Raja
Duke University(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
57
Papers
616
Citations
16
h-index
21
i10-index
Shruti M. Raja is an academic researcher from Duke University. The author has contributed to research in topics: Myasthenia Gravis and Thymoma & Peripheral Neuropathies and Disorders & Magnolia and Illicium research. The author has an h-index of 16, co-authored 49 publications.
ORCID: 0000-0003-0216-1564Papers by this author
worksComparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study
2024 · The Lancet Neurology · 49 citations
https://doi.org/10.1016/s1474-4422(24)00028-0
Dissecting the roles of DR4, DR5 and c-FLIP in the regulation of Geranylgeranyltransferase I inhibition-mediated augmentation of TRAIL-induced apoptosis
2010 · Molecular Cancer · 28 citations
https://doi.org/10.1186/1476-4598-9-23
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat